We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Blackrock
BLK
$169B
| $116M | 0.19% |
231,730
+2,925
| +1% | +$1.39M |
|
102
Colgate-Palmolive
CL
$73.1B
| $116M | 0.19% |
1,677,899
+33,670
| +2% | +$2.3M |
|
103
Becton Dickinson
BDX
$45.6B
| $114M | 0.19% |
431,466
+2,335
| +0.5% | +$582K |
|
104
Prologis
PLD
$135B
| $112M | 0.19% |
1,256,675
+60,649
| +5% | +$5.38M |
|
105
Morgan Stanley
MS
$331B
| $111M | 0.19% |
2,176,715
-1,450
| -0.1% | -$68.6K |
|
106
Vertex Pharmaceuticals
VRTX
$121B
| $110M | 0.18% |
501,645
-9,394
| -2% | -$1.9M |
|
107
Illinois Tool Works
ITW
$82.5B
| $109M | 0.18% |
607,596
+2,469
| +0.4% | +$418K |
|
108
Applied Materials
AMAT
$408B
| $107M | 0.18% |
1,754,956
+13,327
| +0.8% | +$749K |
|
109
Air Products & Chemicals
APD
$65.6B
| $106M | 0.18% |
451,009
+3,715
| +0.8% | +$838K |
|
110
Phillips 66
PSX
$85B
| $105M | 0.18% |
945,918
+27,197
| +3% | +$3.06M |
|
|
MRSH
111
Marsh
MRSH
$90.8B
| $105M | 0.18% |
945,030
+4,218
| +0.4% | +$441K |
|
112
Biogen
BIIB
$30.4B
| $104M | 0.17% |
351,699
-2,052
| -0.6% | -$569K |
|
113
Deere & Co
DE
$160B
| $103M | 0.17% |
595,199
+13,410
| +2% | +$2.31M |
|
114
Ecolab
ECL
$78.3B
| $103M | 0.17% |
531,199
+6,750
| +1% | +$1.28M |
|
115
Simon Property Group
SPG
$74.8B
| $102M | 0.17% |
684,851
+20,390
| +3% | +$3.06M |
|
116
CSX Corp
CSX
$93.5B
| $101M | 0.17% |
4,197,849
-54,831
| -1% | -$1.3M |
|
117
Intercontinental Exchange
ICE
$85.7B
| $101M | 0.17% |
1,090,561
-5,791
| -0.5% | -$537K |
|
118
Equinix
EQIX
$101B
| $98.5M | 0.16% |
168,682
+5,853
| +4% | +$3.29M |
|
|
AGN
119
DELISTED
Allergan plc
AGN
| $97.5M | 0.16% |
509,979
+7,230
| +1% | +$1.3M |
|
120
SLB Ltd
SLB
$73.6B
| $97M | 0.16% |
2,412,847
+55,536
| +2% | +$1.98M |
|
|
SCHW
121
Charles Schwab
SCHW
$183B
| $96.9M | 0.16% |
2,038,005
-12,764
| -0.6% | -$563K |
|
122
Norfolk Southern
NSC
$75.7B
| $96M | 0.16% |
494,769
+5,028
| +1% | +$943K |
|
123
Global Payments
GPN
$23.2B
| $94.9M | 0.16% |
519,594
+12,097
| +2% | +$2.08M |
|
124
Edwards Lifesciences
EW
$49.7B
| $94.7M | 0.16% |
1,217,460
+67,851
| +6% | +$5.3M |
|
125
Kimberly-Clark
KMB
$36.4B
| $94.2M | 0.16% |
685,075
+19,412
| +3% | +$2.63M |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.